Benzinga | Aug 28, 2020 04:16PM EDT

Sinovac Biotech Q2 Adj. EPS $(0.04) Down From $0.12 YoY, Sales $52.30M Down From $64.05M YoY

Sinovac Biotech (NASDAQ:SVA) reported quarterly losses of $(0.04) per share. This is a 133.33 percent decrease over earnings of $0.12 per share from the same period last year. The company reported $52.30 million in sales this quarter. This is a 18.34 percent decrease over sales of $64.05 million the same period last year.